Kiran Mazumdar Shaw, Biocon’s executive chairperson, is delighted that Biocon’s COVID-19 drug Itolizumab is DCGI-approved
15 Jul 2020 8:17 PM
It is important that the country focused on affordability to ensure that technology is accessible to all.
07 Mar 2019 1:21 AM